IPHA logo

Innate Pharma SA (IPHA) Current Assets

Annual Current Assets

$163.61 M
+$13.66 M+9.11%

December 31, 2023


Summary


Performance

IPHA Current Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherIPHAbalance sheetmetrics:

Quarterly Current Assets

$119.62 M
-$43.99 M-26.89%

June 30, 2024


Summary


Performance

IPHA Quarterly Current Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherIPHAbalance sheetmetrics:

Current Assets Formula

Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets

IPHA Current Assets Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+9.1%-23.8%
3 y3 years-23.3%-23.8%
5 y5 years-55.3%-23.8%

IPHA Current Assets Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+9.1%-33.3%at low
5 y5-year-38.5%+9.1%-43.9%at low
alltimeall time-55.3%+551.6%-67.3%+161.2%

Innate Pharma SA Current Assets History

DateAnnualQuarterly
Jun 2024
-
$119.62 M(-26.9%)
Dec 2023
$39.99 M(-45.2%)
$163.61 M(+4.2%)
Jun 2023
-
$156.99 M(+4.7%)
Dec 2022
$72.96 M(-50.1%)
$149.95 M(-16.4%)
Jun 2022
-
$179.46 M(+14.6%)
Dec 2021
$146.33 M(-11.2%)
$156.54 M(+1.4%)
Jun 2021
-
$154.33 M(-27.7%)
Dec 2020
$164.78 M(-10.2%)
$213.34 M(+15.9%)
Jun 2020
-
$184.10 M(-30.8%)
Dec 2019
$183.43 M(+21.9%)
$266.16 M(+8.0%)
Jun 2019
-
$246.36 M(-32.6%)
Dec 2018
$150.51 M(+6.8%)
$365.64 M(+157.9%)
Jun 2018
-
$141.80 M(-14.1%)
Dec 2017
$140.97 M(+158.9%)
$164.98 M(-26.3%)
Jun 2017
-
$223.95 M(-7.9%)
Dec 2016
$54.44 M(-7.5%)
$243.23 M(-2.8%)
Jun 2016
-
$250.13 M(-9.3%)
DateAnnualQuarterly
Dec 2015
$58.85 M(+325.4%)
$275.65 M(-16.5%)
Jun 2015
-
$330.26 M(+242.4%)
Dec 2014
$13.83 M(+53.4%)
$96.45 M(-22.3%)
Jun 2014
-
$124.09 M(+82.1%)
Dec 2013
$9.02 M(-6.6%)
$68.15 M(+48.8%)
Jun 2013
-
$45.80 M(-15.5%)
Dec 2012
$9.65 M(+4.5%)
$54.22 M(-9.7%)
Jun 2012
-
$60.03 M(-12.5%)
Dec 2011
$9.24 M(-5.4%)
$68.62 M(+40.6%)
Jun 2011
-
$48.80 M(-9.8%)
Dec 2010
$9.77 M(-14.1%)
$54.08 M(-7.1%)
Jun 2010
-
$58.22 M(-27.6%)
Dec 2009
$11.37 M(-5.9%)
$80.46 M
Dec 2008
$12.09 M(+9.6%)
-
Dec 2007
$11.03 M(+67.8%)
-
Dec 2006
$6.57 M(+56.1%)
-
Dec 2005
$4.21 M
-

FAQ

  • What is Innate Pharma SA annual total current assets?
  • What is the all time high annual current assets for Innate Pharma SA?
  • What is Innate Pharma SA annual current assets year-on-year change?
  • What is Innate Pharma SA quarterly total current assets?
  • What is the all time high quarterly current assets for Innate Pharma SA?
  • What is Innate Pharma SA quarterly current assets year-on-year change?

What is Innate Pharma SA annual total current assets?

The current annual current assets of IPHA is $163.61 M

What is the all time high annual current assets for Innate Pharma SA?

Innate Pharma SA all-time high annual total current assets is $365.64 M

What is Innate Pharma SA annual current assets year-on-year change?

Over the past year, IPHA annual total current assets has changed by +$13.66 M (+9.11%)

What is Innate Pharma SA quarterly total current assets?

The current quarterly current assets of IPHA is $119.62 M

What is the all time high quarterly current assets for Innate Pharma SA?

Innate Pharma SA all-time high quarterly total current assets is $365.64 M

What is Innate Pharma SA quarterly current assets year-on-year change?

Over the past year, IPHA quarterly total current assets has changed by -$37.37 M (-23.80%)